Literature DB >> 26772430

Subtumoral analysis of PRINT nanoparticle distribution reveals targeting variation based on cellular and particle properties.

Luke E Roode1, Hailey Brighton2, Tao Bo3, Jillian L Perry4, Matthew C Parrott5, Farrell Kersey6, J Chris Luft1, James E Bear7, Joseph M DeSimone8, Ian J Davis9.   

Abstract

The biological activity of nanoparticle-directed therapies critically depends on cellular targeting. We examined the subtumoral fate of Particle Replication in Non-Wetting Templates (PRINT) nanoparticles in a xenografted melanoma tumor model by multi-color flow cytometry and in vivo confocal tumor imaging. These approaches were compared with the typical method of whole-organ quantification by radiolabeling. In contrast to radioactivity based detection which demonstrated a linear dose-dependent accumulation in the organ, flow cytometry revealed that particle association with cancer cells became dose-independent with increased particle doses and that the majority of the nanoparticles in the tumor were associated with cancer cells despite a low fractional association. In vivo imaging demonstrated an inverse relationship between tumor cell association and other immune cells, likely macrophages. Finally, variation in particle size nonuniformly affected subtumoral association. This study demonstrates the importance of subtumoral targeting when assessing nanoparticle activity within tumors. FROM THE CLINICAL EDITOR: Particle Replication in Non-Wetting Templates (PRINT) technology allows the production of nanoparticles with uniform size. The authors in the study utilized PRINT-produced nanoparticles to investigate specific tumor uptake by multi-color flow cytometry and in vivo confocal tumor imaging. This approach allowed further in-depth correlation between nanoparticle properties and tumor cells and should improve future design.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cancer; Flow cytometry; Nanomedicine; Nanoparticle; PRINT

Mesh:

Year:  2016        PMID: 26772430      PMCID: PMC4836989          DOI: 10.1016/j.nano.2015.12.382

Source DB:  PubMed          Journal:  Nanomedicine        ISSN: 1549-9634            Impact factor:   5.307


  36 in total

1.  Nanoparticles target distinct dendritic cell populations according to their size.

Authors:  Vania Manolova; Anna Flace; Monika Bauer; Katrin Schwarz; Philippe Saudan; Martin F Bachmann
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

2.  Antibody targeting of long-circulating lipidic nanoparticles does not increase tumor localization but does increase internalization in animal models.

Authors:  Dmitri B Kirpotin; Daryl C Drummond; Yi Shao; M Refaat Shalaby; Keelung Hong; Ulrik B Nielsen; James D Marks; Christopher C Benz; John W Park
Journal:  Cancer Res       Date:  2006-07-01       Impact factor: 12.701

3.  Different tumor microenvironments contain functionally distinct subsets of macrophages derived from Ly6C(high) monocytes.

Authors:  Kiavash Movahedi; Damya Laoui; Conny Gysemans; Martijn Baeten; Geert Stangé; Jan Van den Bossche; Matthias Mack; Daniel Pipeleers; Peter In't Veld; Patrick De Baetselier; Jo A Van Ginderachter
Journal:  Cancer Res       Date:  2010-06-22       Impact factor: 12.701

4.  Diffusion of particles in the extracellular matrix: the effect of repulsive electrostatic interactions.

Authors:  Triantafyllos Stylianopoulos; Ming-Zher Poh; Numpon Insin; Moungi G Bawendi; Dai Fukumura; Lance L Munn; Rakesh K Jain
Journal:  Biophys J       Date:  2010-09-08       Impact factor: 4.033

5.  Potent engineered PLGA nanoparticles by virtue of exceptionally high chemotherapeutic loadings.

Authors:  Elizabeth M Enlow; J Christopher Luft; Mary E Napier; Joseph M DeSimone
Journal:  Nano Lett       Date:  2011-01-25       Impact factor: 11.189

Review 6.  Delivering nanomedicine to solid tumors.

Authors:  Rakesh K Jain; Triantafyllos Stylianopoulos
Journal:  Nat Rev Clin Oncol       Date:  2010-09-14       Impact factor: 66.675

7.  The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles.

Authors:  Kai Xiao; Yuanpei Li; Juntao Luo; Joyce S Lee; Wenwu Xiao; Abby M Gonik; Rinki G Agarwal; Kit S Lam
Journal:  Biomaterials       Date:  2011-02-04       Impact factor: 12.479

8.  Available volume fraction of macromolecules in the extravascular space of a fibrosarcoma: implications for drug delivery.

Authors:  A Krol; J Maresca; M W Dewhirst; F Yuan
Journal:  Cancer Res       Date:  1999-08-15       Impact factor: 12.701

9.  Selective uptake of multi-walled carbon nanotubes by tumor macrophages in a murine glioma model.

Authors:  Michelle VanHandel; Darya Alizadeh; Leying Zhang; Babak Kateb; Michael Bronikowski; Harish Manohara; Behnam Badie
Journal:  J Neuroimmunol       Date:  2009-01-31       Impact factor: 3.478

10.  Vascular permeability in a human tumour xenograft: molecular charge dependence.

Authors:  M Dellian; F Yuan; V S Trubetskoy; V P Torchilin; R K Jain
Journal:  Br J Cancer       Date:  2000-05       Impact factor: 7.640

View more
  13 in total

1.  The Use of Alternative Strategies for Enhanced Nanoparticle Delivery to Solid Tumors.

Authors:  Mukaddes Izci; Christy Maksoudian; Bella B Manshian; Stefaan J Soenen
Journal:  Chem Rev       Date:  2021-01-14       Impact factor: 60.622

Review 2.  Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior.

Authors:  Miles A Miller; Ralph Weissleder
Journal:  Adv Drug Deliv Rev       Date:  2016-06-04       Impact factor: 15.470

3.  Dissecting Particle Uptake Heterogeneity in a Cell Population Using Bayesian Analysis.

Authors:  Md Shahinuzzaman; Dipak Barua
Journal:  Biophys J       Date:  2020-02-12       Impact factor: 4.033

4.  Targeting Tumor-Associated Fibroblasts for Therapeutic Delivery in Desmoplastic Tumors.

Authors:  Lei Miao; Qi Liu; C Michael Lin; Cong Luo; Yuhua Wang; Lina Liu; Weiyan Yin; Shihao Hu; William Y Kim; Leaf Huang
Journal:  Cancer Res       Date:  2016-11-18       Impact factor: 12.701

Review 5.  Complex effects of tumor microenvironment on the tumor disposition of carrier-mediated agents.

Authors:  Andrew T Lucas; Lauren Sl Price; Allison Schorzman; William C Zamboni
Journal:  Nanomedicine (Lond)       Date:  2017-07-26       Impact factor: 5.307

6.  Docetaxel-Loaded PLGA Nanoparticles Improve Efficacy in Taxane-Resistant Triple-Negative Breast Cancer.

Authors:  Charles J Bowerman; James D Byrne; Kevin S Chu; Allison N Schorzman; Amanda W Keeler; Candice A Sherwood; Jillian L Perry; James C Luft; David B Darr; Allison M Deal; Mary E Napier; William C Zamboni; Norman E Sharpless; Charles M Perou; Joseph M DeSimone
Journal:  Nano Lett       Date:  2016-12-22       Impact factor: 11.189

Review 7.  Nanoparticles and radiotracers: advances toward radionanomedicine.

Authors:  Edwin C Pratt; Travis M Shaffer; Jan Grimm
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2016-03-23

Review 8.  Modulating the Tumor Microenvironment to Enhance Tumor Nanomedicine Delivery.

Authors:  Bo Zhang; Yu Hu; Zhiqing Pang
Journal:  Front Pharmacol       Date:  2017-12-22       Impact factor: 5.810

Review 9.  Prediction of Anti-cancer Nanotherapy Efficacy by Imaging.

Authors:  Miles A Miller; Sean Arlauckas; Ralph Weissleder
Journal:  Nanotheranostics       Date:  2017-07-06

Review 10.  Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment.

Authors:  Jooho Park; Yongwhan Choi; Hyeyoun Chang; Wooram Um; Ju Hee Ryu; Ick Chan Kwon
Journal:  Theranostics       Date:  2019-10-17       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.